ArticleDiagnostic pathology2019

Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study.

Marina Piljić Burazer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.